Muscle weakness in patients with Becker disease is caused by unusual electrical activity in muscle fibres termed 'plateau potentials' that make them temporarily inactive, says a study published today in eLife.
An understanding of these mechanisms and the ion channels involved may help the search for more effective therapies for weakness in Becker disease and other muscle diseases, and help understand how electrical activity is regulated in muscles.
Recessive myotonia congenita, also known as Becker disease, is a heritable skeletal muscle disease caused by mutated chloride channels in the muscles that do not work properly. People with the condition experience a phenomenon called myotonia whereby the muscles are hyperexcitable, meaning they are more sensitive than usual to activation. This results in stiff muscles that struggle to relax after being used.
After moving, patients can also suffer debilitating bouts of weakness that can last from seconds to minutes. "The mechanism underlying this weakness has remained a mystery since its initial description almost 50 years ago," explains first author Jessica Myers, a researcher at the Department of Neuroscience, Cell Biology and Physiology, Wright State University Boonshoft School of Medicine. "There are hints that weakness is due to hypoexcitability, or reduced sensitivity, of muscle fibres, but this conclusion is at odds with the discovery that muscle in Becker disease is hyperexcitable."
Myers and colleagues sought to uncover the mechanisms behind muscle weakness in patients by studying models of Becker disease in mice. They mimicked the disease by inactivating chloride channels either by genetically modifying them or by blocking them with a drug. They then measured how much force the muscles produced and the electrical activity within the muscle cells to see whether weakness was a result of hypo- or hyperexcitability.
The team found that the weakness was caused by temporary depolarisation of the muscle cells which they termed 'plateau potential'. At rest, muscle cells carry a negative electrical charge of -70 to -90 millivolts (mV) relative to their surroundings. When depolarised during a plateau potential, the charge reduces to a less negative state of between -30 and -45 mV which can last up to 100 seconds. Plateau potentials leave muscle fibres inexcitable, making them essentially inactive.
These results suggest that muscle affected by Becker disease rapidly cycles between hyper- and hypoexcitability as individual fibers switch from experiencing myotonia (causing stiffness) to the generation of plateau potentials (causing weakness), respectively. The state depends on the strength of the signal experienced by the muscle fibres: mild depolarisation triggers myotonia and more severe depolarisation triggers the generation of a plateau potential.
The team also demonstrated that both calcium and sodium ion channels are involved in creating a plateau potential, finding that sodium channels trigger this state while calcium channels are responsible for maintaining it. Moreover, blocking a subset of sodium channels with the drug ranolazine prevented the development of plateau potentials and eliminated the temporary muscle weakness.
"Further study is needed to identify all the ion channels involved in the generation of plateau potentials," concludes senior author Mark Rich, Professor at the Department of Neuroscience, Cell Biology and Physiology, Wright State University Boonshoft School of Medicine. "Doing so could lead to the development of novel therapies for weakness in Becker disease as well as similar diseases including periodic paralysis."
###
Media contact
Emily Packer, Media Relations Manager
eLife
e.packer@elifesciences.org
+44 (0)1223 855373
About eLife
eLife is a non-profit organisation created by funders and led by researchers. Our mission is to accelerate discovery by operating a platform for research communication that encourages and recognises the most responsible behaviours. We aim to publish work of the highest standards and importance in all areas of biology and medicine, including Medicine and Neuroscience, while exploring creative new ways to improve how research is assessed and published. eLife receives financial support and strategic guidance from the Howard Hughes Medical Institute, the Knut and Alice Wallenberg Foundation, the Max Planck Society and Wellcome. Learn more at https://elifesciences.org/about.
To read the latest research in Medicine published in eLife, visit https://elifesciences.org/subjects/medicine.
And for the latest in Neuroscience, see https://elifesciences.org/subjects/neuroscience.
About Wright State University
Named after the Wright brothers and located near the historic landmarks where they taught the world to fly, Wright State University is 12 miles northeast of downtown Dayton, Ohio. Wright State serves about 10,000 students and offers nearly 300 undergraduate, graduate, doctoral, and professional degree programs through six colleges and three schools, including the School of Professional Psychology and the Boonshoft School of Medicine. The university operates a regional campus, Wright State University-Lake Campus, on the shores of Grand Lake St. Marys in Celina, Ohio. Between the campuses, the Wright State alumni community is more than 115,000 strong. Visit http://www.wright.edu for more information about Wright State. Additional news stories, media resources and media contacts can be found on the Wright State Newsroom, http://www.wright.edu/news.